Issue link: http://osercommunicationsgroup.uberflip.com/i/310749
C h a i n D ru g s to re D a i l y 2 3 M o n d a y, A p ri l 2 8 , 2 0 1 4 /alert portfolio since 1976. Research shows that over 130,000 pharmacists read Pharm/alert each month. In the 2013 Kantar study, Pharm/alert and e- pharm/alert are ranked No. 1 in total non- journal readership. Pharm/alert Research has direct access to over 100,000 retail and hospital pharmacists with a project /alert ( Cont'd. from p. 1) turn-around time of five days or less. /alert is confident that its 38 years of experience with virtually every pharma- ceutical and/or biotech company and rec- ognized brands such as Pharm /alert and M.D. /alert will get your brand message noticed. For more information, visit www.alert marketing.com or call 800-462-4546. medications to market and benefit all stakeholders in the healthcare equa- tion – patients, prescribers, pharma- cists and payers." Many patients' insurance plans clas- sify esomeprazole strontium as a Tier 1 prescription drug, making it cost efficient for patients. The product is sold through wholesalers and distributors as well as directly to the trade. Indications and Usage Esomeprazole strontium is a proton pump inhibitor (PPI) indicated for adults for: Treatment of gastroe- sophageal reflux disease (GERD); risk reduction of NSAID-associated gastric ulcer; H. pylori eradication to reduce the risk of duodenal ulcer recurrence; and pathological hyper- secretory conditions, including Zollinger-Ellison syndrome. The safety and effectiveness of Amneal Pharmaceuticals ( Cont'd. from p. 12) esomeprazole strontium have not been established in pediatric patients. Esomeprazole strontium is not recom- mended for use in pediatric patients. The safety of esomeprazole stron- tium has not been studied in patients with severe renal impairment. Esomeprazole strontium is not recommended for use in patients with severe renal impairment. Nursing mothers should consider discontinuing esomeprazole strontium. There are no studies in pregnant women. Esomeprazole strontium should be used during pregnancy only if the potential benefits justify the potential risk to the fetus. Important Safety Information (ISI) and full Prescribing Information (PI) are available at www.esomep.com. For more information, stop by Table #302 at the NACDS Annual Meeting, visit www.amneal.com or call 866- 525-7270. increase the basket size up to 25 percent. To convert shoppers into candy buy- ers, Mars Chocolate North America offers these strategies: Anchor the aisle with confections. Draw consumers to the candy aisle with an inviting endcap. Shoppers are attract- ed to displays illustrating key moments – like sponsorships and promotions – that encourage relationships with friends and family. Eye-catching examples include the bright yellow M&M'S ® Brand "Year of Peanut" promotion and SNICKERS ® Brand "NFL Game Day Satisfaction." Maximize confections with cross-purchase adjacencies. Confectionery is a highly popular catego- ry, often purchased with other snack cat- egories. Best-in-class retailers place con- fectionery near popcorn, chips, pretzels, cookies and crackers. Shelving confec- tions adjacent to other snacking cate- gories will encourage basket building. Allocate space to high-performing packs. To reach the most incremental shoppers, retailers must offer a variety of pack types. Allocate over half of everyday chocolate space to laydown bags, fol- lowed by stand-up pouches, six-pack trays and large bars. Mars Chocolate rec- ommends merchandising stand-up pouches at eye level – brand blocked – with snack size items on the bottom shelf. Ensure pack types are blocked hor- izontally within brands. It's important to note that stand-up bag buyers are among the most valuable shoppers to the everyday chocolate cate- Mars ( Cont'd. from p. 1) gory, so this pack size is critical. To help grow the audience of everyday chocolate buyers, retailers should also carry small/medium laydown bags and snack size bags. The ideal confectionery store set places premium chocolate at the end and everyday chocolate in the center. As the anchor in the middle of the aisle, every- day chocolate draws shoppers in, as it facilitates cross-purchasing across adja- cencies. Carry the ideal assortment. When building a plan, retailers should consider a variety of factors, from trends and power brands to consumer insights and industry data. Power brands have broad appeal and high volume, and they serve as segment signposts. Consumers seek out these top brands, which include DOVE ® , M&M'S and SNICKERS Brands in the chocolate segment. Include new items that are on-trend, like the growing bite-sized segment. Consumers like this format that offers the full taste experience of their favorite candy bars in a smaller portion. Look for extensions of power brands, like new 3 MUSKETEERS ® Bites and MILKY WAY ® Simply Caramel Bites. Don't forget the holidays: In the drug channel, seasonal candy represents more than 50 percent of confectionery sales. Place seasonal confections in a central location, plus in secondary dis- plays around the store. Include themed shapes, like TWIX Brand Ghosts and SNICKERS Brand Nutcrackers. To gain additional insights and best practices, retailers should contact their Mars representative or stop by Meeting Space #338. chain drug retailers. Value creation, fast, is what our clients expect and what we deliver. This requires intimate understanding of our client's strategies, and integrated, end- to-end capabilities to ensure seamless execution of a strong plan, and that's what CROSSMARK Drug provides to our clients. An increasing number of retailers and manufacturers in the drug channel are looking for the best ways to leverage shopper data. But making the data action- able is not always easy. Drawing on one of the industry's leading business insights teams, CROSSMARK Drug pro- vides data insights that drive revenues and profits for clients and retailers and create more enjoyable shopper experi- ences for the consumer. Business analytics, including store and consumer-specific targeting and segmentation, help retailers and manu- facturers make better decisions regard- ing assortments, adjacencies, promo- tional planning, pricing and targeted marketing support. As a division of CROSSMARK, a leading sales and marketing services company in the consumer goods indus- CROSSMARK ( Cont'd. from p. 1) try, CROSSMARK Drug has access to proprietary analytics with store-level data from the company's Business Insights group using data from The Nielsen Company, Symphony IRI and other sources. In addition, CROSS- MARK works with clients to analyze and provide insights on retailer-specific loyalty card data. But retailer, shopper and industry data are just part CROSSMARK Drug's deep knowledge of the drug channel. CROSSMARK Drug knows what it takes from both a retailer and manufac- turer perspective to be successful. Our relationships and expertise across all major drug chains provide insights that help us drive effective growth strategies for our clients. CROSSMARK Drug provides man- ufacturers a range of solutions including insights and analytics, customer plan- ning, headquarter sales support and in- store execution. Retailer solutions include management of coordinated mer- chandising programs, category resets and in-store events such as product demos and sampling. For more information, contact Tim Bennett at tim.bennett@crossmark.com or at 630-728-5673. as pursue unique 'difficult to manufac- ture or market' opportunities. A key element of our success has been our focus on providing great service to our customers. While we are a company of less than 40 people, you would never know it. Our team is com- mitted to providing the highest value to all of our customers. We're also backed by the shared services support of one of the world's largest pharma- ceutical companies, Pfizer Inc. Our National Account Directors and Operations departments work in 'cus- tomer-centric' account management teams that are focused on helping our customers meet their objectives. As a result, I believe our people and our account management process are sec- ond to none. With our experience and success in the marketplace, I believe we have become a partner of choice for working with other innovator companies to G reenstone LLC ( Cont'd. from p. 4) launch their generics. CDD: What do you see in Greenstone's future? JC: We plan to continue to grow and com- pete successfully. In fact, we've been sell- ing authorized generics now for over 20 years. In terms of total sales, we have grown from a portfolio of two products in 1993 to a top-10 generics company in the United States, according to an IMS Health report from 2013, based on unbranded generic sales. We have a fine-tuned com- mercial team in place that has developed a great reputation in the marketplace and with customers. The plan going forward for Greenstone is to continue to build the business. We will capitalize on our suc- cess and identify and bring to market new and diversified product opportunities. For more information visit www.GreenstoneLLC.com or call Greenstone LLC Customer Service at 800-447-3360. Cooling Aloe – the first product created expressly to repel biting insects in full sun or no sun, while soothing the skin. Its green applicator signals its cooling aloe formulation, while its distinctive black can says "here is after sun care that con- quers the night." Since its inception in 1989, Sun & Skin Care Research has been dedicated to shielding and nourishing the skin of sun lovers, in and out of the sun, every day and everywhere. Today Sun & Skin Care Research develops, manufactures and dis- tributes globally a wide array of sun pro- tection and skin care products. All prod- ucts are made in Cocoa, Fla. – indeed, the labels fly an American flag and read "Made in USA." The company's bur- Sun & Skin Care Research ( Cont'd. from p. 4) geoning portfolio of brands includes Ocean Potion ® , BullFrog ® , NO-AD ® , and PARROT HEAD™ from Margaritaville ® . Sun & Skin Care Research is posi- tioned as a nimble player ready to com- pete in multiple markets with the giants of the skin care business as worldwide concern about skin cancer continues to mount. The company is proud to deliver customer care disproportionate to its size. In fact, Sun & Skin Care Research's "spend" against the consumer is greater, proportionally, than that of its competi- tors and it consistently offers retailers unmatched service and higher margins than they experience elsewhere. For more information, visit www .sscrllc.com, call 321-633-4644 or stop by Casita #7153 at the show.